Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.32 USD | -3.21% | -4.39% | -14.26% |
Apr. 22 | Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target | MT |
Mar. 28 | Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.26% | 3.23B | |
+3.41% | 32.18B | |
+14.14% | 7.33B | |
+21.71% | 3.83B | |
-27.90% | 1.25B | |
-34.43% | 1.12B | |
+2.01% | 912M | |
-24.21% | 856M | |
-38.47% | 859M | |
-21.04% | 661M |
- Stock Market
- Equities
- EVH Stock
- News Evolent Health, Inc.
- Transcript : Evolent Health, Inc., Q1 2022 Earnings Call, May 04, 2022